Overland Park’s ProPharma Group announced a new CEO.

Dawn Sherman will take on the role on May 14, succeeding founder and CEO Jeff Hargroves. Hargroves will remain on the company’s board.

ProPharma Group offers comprehensive compliance services for pharmaceuticals, biologics and devices. The company, founded in 2001, was acquired in 2016 by Linden Capital Partners, a Chicago-based private equity firm. The one-time startup has grown to more than 750 employees worldwide.

Hargroves is a fellow of Pipeline and earned the entrepreneurial program’s Member Inspiration Award in 2018.

“ProPharma Group is very fortunate to have Dawn join our organization at this time,” Hargroves said. “We are confident that her experience will allow us to accelerate our financial and global growth as a leading provider of compliance related services to the pharmaceutical and medical device industries.”

Sherman comes to ProPharma Group fromEnvisionRxOptions, a subsidiary of RiteAid, where she was president. Previously, she was COO for Teva Pharmaceuticals Europe BV and COO of Medco International BV.

“Dawn has been tremendously successful in building and leading international organizations, and we are excited to have her join the ProPharma Group team to lead the Company through its next phase of growth,” said Michael Farah, partner at Linden Capital.